Detalles de la búsqueda
1.
Second line extracorporeal photopheresis for cortico-resistant acute and chronic GVHD after allogeneic hematopoietic cell transplantation for hematological malignancies: Long-term results from a real-life study.
Transfus Apher Sci
; 63(3): 103899, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38402067
2.
Sickle cell disease and acute leukemia: one case report and an extensive review.
Ann Hematol
; 102(7): 1657-1667, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37269388
3.
Current IST-free/relapse-free survival as a new endpoint after allogeneic hematopoietic stem cell transplantation.
Ann Hematol
; 99(5): 1149-1150, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32185463
4.
Acute graft-versus-host disease, invasive aspergillosis and Clostridium difficile colitis after peripheral blood stem cell transplantation: A complex network of causalities and a challenge for prevention.
Anaerobe
; 33: 98-100, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25749258
5.
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial.
Blood Cancer J
; 14(1): 31, 2024 02 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38374026
6.
Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients.
Cancer
; 119(1): 107-14, 2013 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22744794
7.
Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias.
Blood
; 118(20): 5697-700, 2011 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-21926354
8.
The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis.
Haematologica
; 98(10): 1510-6, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23716543
9.
Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC.
Bone Marrow Transplant
; 58(1): 72-79, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36261707
10.
Phase II prospective study of treosulfan-based reduced-intensity conditioning in allogeneic HSCT for hematological malignancies from 10/10 HLA-identical unrelated donor.
Ann Hematol
; 91(8): 1289-97, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22362122
11.
Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience.
Haematologica
; 96(9): 1276-83, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21606169
12.
Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study.
Bone Marrow Transplant
; 56(6): 1305-1315, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33339900
13.
Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party.
Bone Marrow Transplant
; 56(4): 917-927, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33208915
14.
Lyon-University Hospital Experience with Gemtuzumab Ozogamicin Therapy in Acute Myeloid Leukemia: a 'Real-Life' Study.
Mediterr J Hematol Infect Dis
; 12(1): e2020020, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32395209
15.
Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC).
Bone Marrow Transplant
; 54(10): 1586-1594, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30770870
16.
Elderly Patients (Age 70 Years or Older) With Secondary Acute Myeloid Leukemia or Acute Myeloid Leukemia Developed Concurrently to Another Malignant Disease.
Clin Lymphoma Myeloma Leuk
; 18(5): e211-e218, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29572159
17.
Comparison of the Hemostatic Efficacy of Pathogen-Reduced Platelets vs Untreated Platelets in Patients With Thrombocytopenia and Malignant Hematologic Diseases: A Randomized Clinical Trial.
JAMA Oncol
; 4(4): 468-475, 2018 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29392283
18.
Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience.
Leuk Lymphoma
; 58(1): 110-117, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27184036
19.
Treatment with Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) with Acute Myeloid Leukemia: A Single Institution Experience.
Mediterr J Hematol Infect Dis
; 8(1): e2016009, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26740870
20.
Using EasyMatch® to anticipate the identification of an HLA identical unrelated donor: A validated efficient time and cost saving method.
Hum Immunol
; 77(11): 1008-1015, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26902994